Here we report for the first time metabolic abnormalities in white matter lesions of COVID-19 patients using MR-spectroscopic imaging. The study compares metabolic changes in COVID-19 patients to those seen in other encephalopathies and a normal control case. Findings include NAA reduction indicating neuronal injury/loss, and choline and myo-inositol elevation indicating demyelination and neuroinflammation, respectively. One COVID-19 patient exhibited pronounced lactate elevation consistent with "silent hypoxia". Other factors may be involved considering the degree of metabolic changes seen in these patients when compared to other COVID-19 cases without similar white matter changes as well as other white matter disorders.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords